VIM
DNLI icon

VELA Investment Management’s Denali Therapeutics DNLI Stock Holding History

VELA Investment Management’s Portfolio DNLI Stock Details DNLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-27,771
Closed -$378K – 168
2025
Q1 		$378K Buy
27,771
+12,136
+78% +$233K 0.13% 139
2024
Q4 		$319K Hold
15,635
– – 0.11% 149
2024
Q3 		$455K Buy
+15,635
New +$388K 0.16% 139
2024
Q1 		– Sell
-26,145
Closed -$561K – 165
2023
Q4 		$561K Buy
26,145
+6,246
+31% +$124K 0.23% 125
2023
Q3 		$411K Sell
19,899
-773
-4% -$19.6K 0.18% 117
2023
Q2 		$610K Hold
20,672
– – 0.28% 101
2023
Q1 		$476K Buy
20,672
+6,926
+50% +$191K 0.22% 116
2022
Q4 		$382K Buy
13,746
+4,905
+55% +$146K 0.19% 119
2022
Q3 		$271K Buy
+8,841
New +$287K 0.15% 129

Other funds holding DNLI

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $29.7B AUM 13.98% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return